Dr. Ahmed Saad, MD

Dr. Saad practices at Houston Surgery Center in Houston, Texas.

Dr. Saad's NPI, 1104340066, was assigned on August 1, 2017. Dr. Saad graduated from Zagazig University Faculty of Medicine in 2006. Dr. Saad holds Texas license U7506.

Dr. Saad's primary practice is Houston Surgery Center, at 6655 Travis St, Houston, TX 77030 in Harris County. The practice phone is (713) 335-1700.

Dr. Saad's primary practice is Houston Surgery Center in Houston, Texas. Dr. Saad is also affiliated with Saunders Medical Center. The medical group on file is Concord Medical Group. Dmand AI also links Dr. Saad to 7 more medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saad practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Saad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Saad is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Saad's licenses on file in 4 states: Texas, Nebraska, Iowa and Illinois.

Dmand AI lists acute diabetes, acute respiratory failure, cardiac arrhythmia, cellulitis, circulatory problems in extremities, dementia, electrolyte disorders and joint pain among the conditions Dr. Saad treats.

CMS data shows 396 Medicare services from Dr. Saad across 5 procedure codes in 2024, for 156 Medicare patients. Medicare paid $33,675 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Dr. Saad in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saad's median patient age at 42, with 48% women.

In 2024, Dr. Saad wrote 257 Medicare Part D claims for 119 patients. 89% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $511 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Saad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 57 papers to Dr. Saad, published from 2009 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Renal Artery Obstruction, Kidney and Renal Circulation. Dr. Saad has published most often in Nephrol Dial Transplant. Dr. Saad's most frequent co-authors are Sanjay Misra, MD, Sandra M. Herrmann, MD and James Glockner, MD.

Dmand AI links Dr. Saad to 3 clinical trials, 2 of them phase 1 studies. Conditions studied include Hypertension, Renovascular, Hypertension, Renal and Renal Artery Obstruction. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 12 general payments to Dr. Saad from 7 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Dutch Ophthalmic, USA paid the most, $131.

Dmand AI lists 2 awards for Dr. Saad, most recently Assistant Professor of Medicine in 2014.

Dr. Saad graduated from Zagazig University Faculty of Medicine in 2006.

Dr. Saad is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.